Journal
JOURNAL OF COMPARATIVE PATHOLOGY
Volume 151, Issue 4, Pages 347-351Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jcpa.2014.07.003
Keywords
histiocytic disorder; immunohistochemistry; ionized calcium-binding adapter molecule 1; monocyte/macrophage
Categories
Funding
- National Council for Research and Development (CNPq-Brazil) [246420/2012-0]
Ask authors/readers for more resources
Ionized calcium-binding adapter molecule 1 (Ibal) has been used widely as a marker for microglial cells and, recently, was also recognized as a 'pan-macrophage marker', as it is expressed by all subpopulations of cells of the monocyte/macrophage lineage. To determine the specificity of Ibal as an immunohistochemical marker for canine and feline histiocytic proliferative, neoplastic and inflammatory disorders of the skin, we evaluated its expression in two types of histiocytic tumours, two non-neoplastic histiocytic proliferative conditions, one case of granulomatous dermatitis and four non-histiocytic tumours. Cells of the monocyte/macrophage lineage in all cases of canine cutaneous histiocytoma (9/9), reactive histiocytosis (9/9), histiocytic sarcomas (5/5), feline progressive dendritic cell histiocytosis (3/3) and macrophages in cutaneous mycobacteriosis (7/7) showed strong cytoplasmic expression of Ibal. Neoplastic cells of melanomas (10/10), lymphomas (7/7), mast cell tumours (7/7) and plasmacytomas (4/4) did not express Ibal. Ibal is therefore a useful marker of cells of the monocyte/macrophage lineage in canine and feline inflammatory, proliferative and neoplastic conditions and can be used to identify these cells in formalin-fixed, paraffin wax-embedded tissues. Ibal is not able to differentiate between macrophages and dendritic antigen presenting cells and expression does not allow classification of these histiocytic disorders. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available